Exploring how genomic medicine can improve healthcare for diverse populations in New York City
GeNYC: Genomic Implementation Research in the Diverse Settings and Populations of New York City
This study is looking at how using genetic information can improve healthcare for diverse communities in New York City, especially for African and Latino populations, by making it easier for doctors to help prevent and manage chronic diseases.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10456789 on NIH RePORTER |
What this research studies
This research focuses on implementing genomic medicine to enhance healthcare delivery and health equity among diverse populations in New York City. The GeNYC team collaborates with various stakeholders, including patients and clinicians, to conduct clinical trials aimed at chronic disease prevention and control. By engaging community sites and utilizing genomic information, the team seeks to make genetic risk assessments relevant and accessible to underrepresented groups, particularly African ancestry and Latino populations. The research includes pragmatic clinical trials that test the incorporation of genetic risk information into primary care settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults from diverse backgrounds, particularly those of African ancestry or Latino descent, who are at risk for chronic diseases such as hypertension.
Not a fit: Patients who do not belong to the targeted demographic groups or those without chronic disease risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective healthcare strategies for chronic diseases, particularly for diverse populations.
How similar studies have performed: Previous studies have shown success in implementing genomic medicine in diverse populations, indicating a promising approach for this research.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Horowitz, Carol R — Icahn School of Medicine at Mount Sinai
- Study coordinator: Horowitz, Carol R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.